LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
US takes first steps to rein in abusive and privacy-invasive use of AI by corporations.
After delays in sentencing and attempts by her legal team to win a mistrial, Holmes was sentenced last week for her role in defrauding investors of millions.
Where your remote employees actually work may have significant legal consequences for your lab.
While again light on lab-related cases, this week’s healthcare-related enforcement actions featured improper billing, kickbacks, and telemedicine.
POC tests offer speed and simplicity, but are less reliable than tests performed in labs.
FDA confirms the new rule, which will update the Mammography Quality Standards Act, will publish before the end of 2022, or early 2023.
Medical device makers will have to show that their products will be accessible to disadvantaged populations.
In case you don’t feel like reading all 3,300+ pages of the Final Rule, here’s a quick briefing on the main changes you should be aware of.
Though light on lab-related cases, last week’s enforcement actions cracked down on COVID-19-related violations.
However, the increase still isn’t enough to keep pace with inflation, providers contend.